From: Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression
| Diabetic Neuropathy (DN) Cohort Compared to Diabetes (DM) Cohort | ||
|---|---|---|
| Cost Component | Comparative Costs | P Value |
| Total Direct Medical Costs | $4819.29 v $24,764.91 | * |
| Inpatient Costs | $1,004.78 v $7,282.16 | * |
| Outpatient Costs | $2,548.09 v $14,137.98 | * |
| ER Costs | $178.28 v $889.25 | * |
| Pharmaceutical Costs | $1,098.28 v $5,622.53 | * |
| Diabetes-Related Total Direct Medical Costs | $1,296.79 v $5,125.10 | * |
| Diabetes and Depression (DD) Cohort Compared to Diabetes (DM) Cohort | ||
| Cost Component | Comparative Costs | P Value |
| Total Direct Medical Costs | $4,819.29 v $19,397.59 | * |
| Inpatient Costs | $1,004.78 v $3,644.51 | * |
| Outpatient Costs | $2,548.09 v $10,895.46 | * |
| ER Costs | $178.28 v $833.85 | * |
| Pharmaceutical Costs | $1,098.28 v $6,526.86 | * |
| Diabetes-Related Total Direct Medical Costs | $1,296.79 v $3,263.81 | * |
| Diabetic Neuropathy (DN) Cohort Compared to Diabetes and Depressed (DD) Cohort | ||
| Cost Component | Comparative Costs | P Value |
| Total Direct Medical Costs | --- | NS |
| Inpatient Costs | $3,011.01 v $4,167.12 | ** |
| Outpatient Costs | $8,109.09 v $8,861.53 | *** |
| ER Costs | --- | NS |
| Pharmaceutical Costs | --- | NS |
| Diabetes-Related Total Direct Medical Costs | $2,783.23 v $3,455.54 | * |